Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04439474

Enrollment

187

Registered

2020-06-19

Start date

2018-10-10

Completion date

2020-02-10

Last updated

2020-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

This study looked at the effect of vitamin D levels on the complications of type 2 diabetes and the fat profile of patients with diabetes.Participants in this study were divided into two groups. One group included participants with vitamin D deficiency and the other group did not.The first group receives 50,000 units of oral vitamin D 3 daily for up to 8 days.

Interventions

DRUGVitamin D3

For up to 8 days, 50,000 units of vitamin D3 are given daily to patients in the first group so that the serum level of vitamin D reaches above 30 g / ml.

DRUGRoutine treatment

In this group, patients receive their usual medications and treatments

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with type 2 diabetes * Having conscious satisfaction

Exclusion criteria

* Patients with a history of gastrointestinal surgery * Patients with a history of renal failure * Patients with a history of vitamin D intake and calcium-containing compounds * Patients with a history of liver disease

Design outcomes

Primary

Measure	Time frame	Description
Vitamin D serum levels	up to 1 year	Vitamin D serum levels measured by blood tests
Triglyceride	up to 1 year	Level of blood triglycerides measured by a blood test
Blood cholesterol levels	up to 1 year	Blood cholesterol levels measured by a blood test
HDL	up to 1 year	Blood HDL levels measured by a blood test
LDL	up to 1 year	Blood LDL levels measured by a blood test
Fasting blood glucose	up to 1 year	Fasting blood glucose levels measured by a blood test
Neuropathy	up to 1 year	Neuropathy based on United Kingdom Screening TEST
Nephropathy	up to 1 year	Nephropathy based on albumin excretion evaluation
Retinopathy	up to 1 year	Retinopathy based on an ophthalmologist's examination
blood pressure	up to 1 year	Systolic and diastolic blood pressure measured by Sphygmomanometer
HBA1C	up to 1 year	Blood sugar levels measured in the last three months measured by blood test

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026